Diogene
Diogene is a molecular diagnostics company specializing in rapid and accurate genetic testing for various diseases, including cancer, infectious diseases, and pet health. They develop and provide innovative diagnostic kits and services, leveraging core technologies such as multiplex real-time PCR, RT-LAMP, and exosome analysis. The company aims to contribute to early disease detection, personalized medicine, and health management through advanced molecular diagnostics and strategic partnerships.
Industries
Nr. of Employees
small (1-50)
Diogene
190-1, Sangdaewon-dong, Jungwon-gu, Seongnam-si, Gyeonggi-do, Korea
Products
Sample collection kits and nucleic acid extraction kits
Kits for specimen collection and nucleic acid extraction to support molecular diagnostic assays.
COVID-19 RT-LAMP diagnostic kit
RT-LAMP based reagent kit for rapid detection of SARS-CoV-2; designed for short time-to-result screening.
Rapid monkeypox (MPXV) nucleic acid detection kit
Molecular diagnostic kit for detection of monkeypox virus intended for rapid identification of infection.
MARV RT-LAMP rapid diagnostic kit
RT-LAMP based rapid diagnostic reagent for detection of Marburg virus (MARV) with short time-to-result.
Real-time PCR hepatitis virus detection kit
Real-time PCR reagent kit for detection of hepatitis viruses (HAV, HBV, HCV) from clinical samples.
miRNA-based cancer diagnostic assay (breast cancer biomarker panel)
Multi-miRNA biomarker panel and associated algorithm developed to distinguish breast cancer patients from controls with improved early-detection performance.
Sample collection kits and nucleic acid extraction kits
Kits for specimen collection and nucleic acid extraction to support molecular diagnostic assays.
COVID-19 RT-LAMP diagnostic kit
RT-LAMP based reagent kit for rapid detection of SARS-CoV-2; designed for short time-to-result screening.
Rapid monkeypox (MPXV) nucleic acid detection kit
Molecular diagnostic kit for detection of monkeypox virus intended for rapid identification of infection.
MARV RT-LAMP rapid diagnostic kit
RT-LAMP based rapid diagnostic reagent for detection of Marburg virus (MARV) with short time-to-result.
Real-time PCR hepatitis virus detection kit
Real-time PCR reagent kit for detection of hepatitis viruses (HAV, HBV, HCV) from clinical samples.
miRNA-based cancer diagnostic assay (breast cancer biomarker panel)
Multi-miRNA biomarker panel and associated algorithm developed to distinguish breast cancer patients from controls with improved early-detection performance.
Services
Laboratory genetic testing service for cancer-related and other disease-associated markers, provided in coordination with medical institutions.
Gut and oral microbiome profiling service providing relative quantification of microbial taxa and risk indices for disease associations.
Companion animal microbiome profiling and genetic screening for hereditary and chronic conditions, deployed in B2B campaigns and partner programs.
Collaborative product development, licensing/technology transfer, and OEM manufacturing tailored to partner requirements using in-house assay platforms.
Laboratory genetic testing service for cancer-related and other disease-associated markers, provided in coordination with medical institutions.
Gut and oral microbiome profiling service providing relative quantification of microbial taxa and risk indices for disease associations.
Companion animal microbiome profiling and genetic screening for hereditary and chronic conditions, deployed in B2B campaigns and partner programs.
Collaborative product development, licensing/technology transfer, and OEM manufacturing tailored to partner requirements using in-house assay platforms.
Expertise Areas
- Clinical genetic testing
- Molecular diagnostics development
- Microbiome analysis (human and veterinary)
- Biomarker discovery (miRNA and exosome biomarkers)
Key Technologies
- Real-time PCR (qPCR)
- RT-LAMP isothermal amplification
- Multiplex PCR
- Dual-signal/multi-amplification nucleic acid amplification
News & Updates
Development of a rapid diagnostic kit for Monkeypox virus, capable of detection within 1 hour.
Registration of a patent for a multi-miRNA biomarker panel for early breast cancer diagnosis.
Development of a real-time PCR kit for rapid detection of hepatitis A, B, and C viruses.
Development of a rapid diagnostic kit for Marburg virus, a highly lethal hemorrhagic fever virus.
A test to predict biological age and disease risk based on telomere length.
Patent application for a method of early cancer diagnosis using exosomes.
Development of a rapid diagnostic kit for Monkeypox virus, capable of detection within 1 hour.
Registration of a patent for a multi-miRNA biomarker panel for early breast cancer diagnosis.
Development of a real-time PCR kit for rapid detection of hepatitis A, B, and C viruses.
Development of a rapid diagnostic kit for Marburg virus, a highly lethal hemorrhagic fever virus.
A test to predict biological age and disease risk based on telomere length.
Patent application for a method of early cancer diagnosis using exosomes.